# Oral Vitamin C Administration on Erythropoietin Dosing Requirement in End-Stage Renal Disease Patients on Regular Hemodialysis

> **NCT07076108** · NA · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Vitamin C
- Oral Administration
- Erythropoietin
- End-Stage Renal Disease
- Regular Hemodialysis

## Interventions

- **DRUG:** Normal regimen of treatment of anemia
- **DRUG:** Vitamin C
- **DRUG:** Vitamin C

## Key facts

- **NCT ID:** NCT07076108
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-01
- **Primary completion:** 2024-04-28
- **Final completion:** 2024-04-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07076108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07076108, "Oral Vitamin C Administration on Erythropoietin Dosing Requirement in End-Stage Renal Disease Patients on Regular Hemodialysis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07076108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*